As classes kicked off for the fall semester at the University of Tampa Monday, sophomores are returning to campus with a brand new class on their schedule – and it’s all about generative artificial ...
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with ...
Cytokinetics (NASDAQ:CYTK) presented primary results from its Phase III ACACIA-HCM trial evaluating aficamten in patients ...
ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both ...
Aldeman: The school staffing boom may finally be ending. Still, most districts serve fewer kids per educator than they did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results